审查树突细胞疫苗在中断乳腺癌发展中的重要性
Namrata Gautam1, Ganesan Ramamoorthi1, Nicholas Champion2
1Clinical Science & Immunology Program, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Molecular aspects of medicine
|December 27, 2023
概括
树突细胞疫苗通过激活对瘤的免疫反应,对乳腺癌的预防和治疗充满希望. 本综述探讨了它们在调节免疫力以对抗乳腺癌发展中的作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 乳腺癌是一种普遍且异质的疾病,在美国,每8名女性中就有1名患有乳腺癌.
- 免疫疗法通过调节免疫系统,为癌症治疗提供了一个有希望的途径.
- 状细胞在启动对癌细胞的免疫反应中起着至关重要的作用.
研究的目的:
- 审查树突细胞 (DC) 疫苗在治疗乳腺癌中的重要性.
- 为了突出针对DC疫苗的向codrivers和新抗原的逻辑.
- 讨论DC疫苗在预防乳腺癌方面的潜力.
主要方法:
- 审查关于树突细胞子集和成熟状态的现有文献,以开发疫苗.
- 对瘤驱动和新抗原在乳腺瘤发生中的作用的分析.
- 检查1型树突细胞疫苗的内注射激活的免疫反应机制.
主要成果:
- 1型树突细胞疫苗的内注射激活了瘤抗原特异性的CD4+ T辅助1型 (Th1) 细胞.
- 这种激活促进了抗瘤原生的免疫反应.
- 该疗法同时阻断了亲瘤原生的免疫反应.
结论:
- 树突细胞疫苗代表了乳腺癌免疫疗法的重大进展.
- 用DC疫苗向coddrivers和新抗原提供了一个合理的治疗策略.
- 需要进一步的研究来优化树突细胞疫苗设计,以有效预防和治疗乳腺癌.
更多相关视频
相关概念视频
Cancer Vaccines
370
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
370
Vaccinations
44.5K
Overview
44.5K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K


